Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March–May 2006

Authors

  • Vicky Sheppeard NSW Department of Health
  • Bradley Forssman Sydney South West Area Health Service
  • Mark J Ferson Public Health Unit, South East Sydney Illawarra; School of Public Health and Community Medicine, University of New South Wales
  • Conrad Moreira Sydney West Area Health Service
  • Sue Campbell-Lloyd NSW Department of Health
  • Dominic E Dwyer Sydney West Area Health Service; Institute of Clinical Pathology and Medical Research
  • Jeremy M McAnulty NSW Department of Health

DOI:

https://doi.org/10.33321/cdi.2009.33.3

Keywords:

measles-mumps-rubella vaccine, vaccine effectiveness, disease outbreaks, child

Abstract

During March to May 2006 the highest incidence of measles in New South Wales since 1998 provided an opportunity to estimate the effectiveness of the measles-mumps-rubella (MMR) vaccination program in preventing childhood measles, and describe any differences in clinical presentation between vaccinated and unvaccinated children. We reviewed records of all 33 notified cases of measles in children aged 1–14 years during a state-wide outbreak in New South Wales from March – May 2006. Six of the children had a confirmed history of vaccination with at least 1 dose of MMR. The children with previous vaccination tended to have milder disease than those without vaccination as judged by their reported number of symptoms and hospitalisation rates. The vaccinated children were less likely to have a typical measles rash. Two of the cases in previously vaccinated children may be due to secondary vaccine failure, although a lack of complete diagnostic testing limits our ability to confirm this. Vaccine effectiveness after receiving at least 1 dose of MMR is estimated to be 96% (95% CI 77.8–99%). MMR vaccination was effective in preventing measles in children during these outbreaks. Commun Dis Intell 2009;32:21–26.

Downloads

Download data is not yet available.

References

NSW Department of Health. Communicable Diseases Report for May and June 2006. N S W Public Health Bull 2006;17:122–127.

Gidding HF, Burgess MA, Kempe AE. A short history of vaccination in Australia. Med J Aust 2001;174:37–40.

NSW Department of Health. Notifiable Diseases Database System (NDD)(HOIST). Communicable Diseases Branch and Epidemiology and Surveillance Branch, NSW Health Department.

Australian Childhood Immunisation Register, Quarterly reports to NSW Department of Health, 1999–2008.

Adu FD, Ikusika A, Omotade O. Measles outbreak in Ibadan: clinical, serological and virological identification of affected children in selected hospitals. J Infect 1997;35:241–245.

Aurangzeb B, Nisar YB, Hazir T, Burki F, Hassan M. Clinical outcome in children hospitalized with complicated measles. J Coll Physicians Surg Pak 2005;15:547–551.

van Eijndhoven MJ, Rumke HC, Bosman A, van Dijk WC, Hirsch R, van Binnendijk RS. A measles epidemic in an adequately vaccinated middle school population. Ned Tijdschr Geneeskd 1994;138:2396–2400.

Moss WJ, Pollack FP. Immune responses to measles and measles vaccine: challenges for measles control. Viral Immunol 2001;14:297–309.

Australian Government Department of Health and Ageing. Measles case definition.[online] Available from: http://www.health.gov.au/internet/main/publishing.nsf/content/cda-surveil-nndss-casedefs-cd_measl.htm

NSW Department of Health. NSW Measles Response Protocol. NSW Department of Health 2004. Available from: http://www.health.nsw.gov.au/infect/pdf/measles.pdf Accessed 3 July 2006

Weston KM, Dwyer DE, Ratnamohan M, McPhie K, Chan SW, Branley JM, et al. Nosocomial and community transmission of measles virus genotype D8 by a returning traveller from Nepal. Commun Dis Intell 2006;30:358–365.

Centers for Disease Control and Prevention. Epi Info version 3.2, Database and Statistics Software for Public Health Professionals. Centers for Disease Control and Prevention, Atlanta: 2004.

Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993;22:742–746.

Lee KY, Lee HS, Hur JK, Kang J-H, Lee BC. Clinical features of measles according to age in a measles epidemic. Scand J Infect Dis 2005;37:471–475.

Ariyasriwatana C, Kalayanarooj S. Severity of measles: a study at the Queen Sirikit National Institute of Child Health. J Med Assoc Thai 2004;87:581–588.

Top of page

Ibrahim SA, Mustafa OM, Mukhtar MM, Saleh EA, El Mubarak HS, Abdallah A, et al. Measles in suburban Khartoum: an epidemiological and clinical study. Trop Med Int Health 7:442–449.

Edmonson MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 1990;263:2467–2471.

World Health Organization. Measles vaccines. Wkly Epidemiol Rec 2004;14:130–142.

Erdman DD, Health JL, Watson JC, Markowitz LE, Bellini WJ. Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol 1993;41:44–48.

Ratnam S, Tipples G, Head C, Fauvel M, Fearon M, Ward BJ. Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J Clin Microbiol 2000;38:99–104.

Panutti CS, Morello Rj, Moraes JC, Curti SP, Afonso AM, Camargo MC, et al. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic. Clin Diagn Lab Immunol 2004;11:119–122.

Public Health Laboratory Network. Measles case definition, Communicable Diseases Network Australia, 2001. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-phlncd-measles.htm/$FILE/Measles%20CD.pdf Accessed 3 July 2006.

Minnich LL, Goodenough F, Ray CG. Use of immunofluorescence to identify measles virus infections. J Clin Microbiol 1991;29:1148–1150.

PAHO. Measles Elimination Field Guide. 2nd Edn. Pan American Health Organization. Washington DC, 2005.

Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis 2003;187 Suppl 1:S283–S290.

Torvaldsen S, McIntyre PB. Observational methods in epidemiological assessment of vaccine effectiveness. Commun Dis Intell 2002;26:451–457.

Hull BP, Lawrence GL, MacIntyre CR, McIntyre PB. Immunisation coverage in Australia corrected for under-reporting to the Australian Childhood Immunisation Register. Aust N Z J Public Health 2003;27:533–538.

Botham SJ, Poulos RG, McFarland KJ, Ferson MJ. Getting it right – the Australian Childhood Immunisation Register and immunisation rates in south-eastern Sydney. Aust N Z J Public Health 2004;28:68–71.

MacIntyre CR, Hull B, Burgess M, Gay N. Measles control in NSW Divisions of General Practice. N S W Public Health Bull 2003;14;13–17.

Downloads

Published

01/03/09

How to Cite

Sheppeard, Vicky, Bradley Forssman, Mark J Ferson, Conrad Moreira, Sue Campbell-Lloyd, Dominic E Dwyer, and Jeremy M McAnulty. 2009. “Vaccine Failures and Vaccine Effectiveness in Children During Measles Outbreaks in New South Wales, March–May 2006”. Communicable Diseases Intelligence 33 (March):21-26. https://doi.org/10.33321/cdi.2009.33.3.

Most read articles by the same author(s)

1 2 3 4 5 > >>